# Relative Bioavailability Study of HRG2010 in Healthy Subjects

> **NCT06976346** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** HRG2010 Capsule, Sinemet®, Madopar®

## Key facts

- **NCT ID:** NCT06976346
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-10
- **Primary completion:** 2021-10-07
- **Final completion:** 2021-10-07
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2025-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06976346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06976346, "Relative Bioavailability Study of HRG2010 in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06976346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*